Abstract:Guiyun Zhang, 1 Zhe Liu, 1 Zhen Li, 2 Yangchun Xu 1 1 Department of Dermatology, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China; 2 Department of Medical Administration, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China Correspondence: Yangchun Xu, Department of Dermatology, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Nanguan District, Changchun, 130041, People's Republic of China, Tel +86-431-81136244, Email Keloids are pathologic scars that pose a significant functional and cosmetic burden. While the literature on keloid management continues to expand, the absence of standardized guidelines or treatment protocols endorsed by academic governing bodies remains a significant challenge. The pathogenesis of keloid scars is not fully elucidated. This review delves into the intricate pathogenesis of keloids, exploring the molecular and cellular mechanisms underlying their formation. Conventional therapies are analyzed in-depth considering their efficacy and limitations, including surgical excision, pharmacotherapies, radiotherapy, cryotherapy, silicone-based product, pressure therapy, and light-based therapy. The emergence of novel therapeutic approaches is discussed, including pharmacotherapies, physical therapies, and biological therapies, shedding light on their potential in treating keloid scars. We also contemplate future directions in the field, encompassing the application of targeted therapies, gene-editing tools, tissue engineering, and regenerative medicine, together with psychosocial support and patient education. In synthesizing current knowledge, scrutinizing therapeutic modalities, and envisioning future avenues, this review aims to provide a comprehensive reference for clinicians, researchers, and stakeholders engaged in the intricate field of keloid management. Keywords: keloid scars, pathogenesis, therapies Keloid scars represent a perplexing challenge in dermatology, characterized by an abnormal wound healing process that extends beyond the original injury site. 1 The raised, often painful, and cosmetically disfiguring scars pose both clinical and psychological burdens for affected individuals. Despite their prevalence, the precise etiology of keloids remains elusive, and their pathogenesis involves intricate interactions between genetic, immunologic, and environmental factors. 2 Understanding the underlying mechanisms driving keloid formation is essential for developing effective therapeutic strategies. In addition, there is a need to revisit rapidly evolving therapies. In this review, we delve into the intricate cellular processes and molecular pathways implicated in the pathogenesis of keloid scar formation. Additionally, we scrutinize the current landscape of therapeutic interventions, ranging from conventional therapies to emerging innovative approaches, with a focus on their efficacy and potential side effects. Through a nuanced exploration of both the molecular intricacies and therapeutic modalities, this review aims to contribute to the advancement of our knowledge and the refinement of strategies for the management of keloid scars. Keloid pathogenesis is a multifaceted process involving a dynamic interplay of various cells, cytokines, and signaling pathways (Figure 1). A deeper understanding of these mechanisms opens avenues for targeted therapeutic interventions aimed at disrupting the cascade of events leading to keloid formation. By dissecting the intricacies of keloid pathology, we move closer to more effective and personalized approaches for the management of this challenging dermatological condition. Figure 1 Schematic diagram of interactions between various cells, cytokines, and signaling pathways leading to keloid formation. Red arrows represent facilitation and green arrows represent inhibition. Macrophages can polarize into two main phenotypes depending on different microenvironments. The infiltration of M2 macrophages is significantly higher than that of M1 macrophages in keloid tissue. CD4+ T cells can be categorized into Th1, Th2, and regulatory T cells (Tregs). Th1 cells can attenuate the tissue fibrosis by releasing IFN-γ. IL-4 and IL-13 secreted by Th2 cells facilitate to the synthesis of collagen, which consequently result in deposition of reticular fibrin. Tregs can inhibit the immune function other effector T cells and maintain peripheral immune tolerance. Mast cells can increase type I collagen synthesis by stimulating fibroblast proliferation through the release of VEGF, IL-4, as well as bFGF. Fibroblasts are one of the major cells in keloid tissues. The fibroblast density in keloids is higher and the proliferation rate is increased, but the apoptosis rate is reduc -Abstract Truncated-

Natural killer cell dysfunction drives keloid pathogenesis

Exosomes Released by Melanocytes Modulate Fibroblasts to Promote Keloid Formation:A Pilot Study

HIF-1α Promotes the Keloid Development Through the Activation of TGF-β/Smad and TLR4/MyD88/NF-κB Pathways.

Genome-wide Analysis of Dysregulated RNA-binding Proteins and Alternative Splicing Genes in Keloid

Single-Cell RNA-Sequencing Reveals Lineage-Specific Regulatory Changes of Fibroblasts and Vascular Endothelial Cells in Keloids

The mechanism of TGF-β mediating BRD4/STAT3 signaling pathway to promote fibroblast proliferation and thus promote keloid progression

Characterization of the skin keloid microenvironment

Revisiting roles of mast cells and neural cells in keloid: exploring their connection to disease activity

The Polygenic Map of Keloid Fibroblasts Reveals Fibrosis-Associated Gene Alterations in Inflammation and Immune Responses

Increased Melanin Induces Aberrant Keratinocyte−melanocyte−basal−fibroblast Cell Communication and Fibrogenesis by Inducing Iron Overload and Ferroptosis Resistance in Keloids

Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids

Keloidal Pathophysiology: Current Notions.

Dysregulation of DPP4-CXCL12 Balance by TGF-β1/SMAD Pathway Promotes CXCR4+ Inflammatory Cell Infiltration in Keloid Scars

TWEAK/Fn14 Signaling May Function As a Reactive Compensatory Mechanism Against Extracellular Matrix Accumulation in Keloid Fibroblasts.

Keloid Disorder: Genetic Basis, Gene Expression Profiles, and Immunological Modulation of the Fibrotic Processes in the Skin

Expansion of CD26 Positive Fibroblast Population Promotes Keloid Progression

Epigenetic modification mechanisms involved in keloid: current status and prospect

Single‐cell RNA sequencing highlights the role of proinflammatory fibroblasts, vascular endothelial cells, and immune cells in the keloid immune microenvironment

Transcriptome Network Analysis of Inflammation and Fibrosis in Keloids.

Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1

Future Directions About Keloid Scars Based on Pathogenesis and Therapies